You are here

KSHB NEWS: New FDA-approved device tested at Saint Luke's helps patients with central sleep apnea

Untreated central sleep apnea can not only lead to extreme fatigue and memory loss but also much more severe side effects including diabetes, congestive heart failure, and death.  For years there were not real treatment options for these patients.  However, that all recently changed as the FDA approved a new device which has shown very promising results.  KSHB reporter Rae Daniel interviewed one patient whose life was changed by this device and shares how research at Saint Luke's made that possible.